A further issue for consideration is the use of concomitant medications (e.g., aspirin ... in End-points Through Aggressive Lipid Lowering; LDL-C = LDL-cholesterol; MI = Myocardial infarction ...

Statins are commonly prescribed medications that help lower high cholesterol levels, reducing the risk of heart disease. Among these, rosuvastatin is a popular option because of its strong ...

Trials of High-dose Statin Therapy in Subjects with Acute Coronary Syndromes Three clinical trials - Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL), The Pravastatin or ...

A recent study found that more than 5 years of taking medications like blood pressure and lipid-lowering drugs was associated with a lower incidence of dementia. At the same time, researchers ...

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.

Cholesterol-lowering drugs may soon be routinely prescribed to people with diabetes, it emerged today. The Government promised to act upon the findings of a major study, which showed that more ...

Here are some of them: Garlic which is often used in soups in fresh form or as powder can help lower total cholesterol and triglyceride ... to be generally safe for up to 8 grams per day.

antihypertensives — drugs that treat high blood pressure lipid-lowering medications — drugs that treat high cholesterol diuretics — drugs that stimulate the elimination of excess salt and ...

The cholesterol-lowering drug has been classed as a breakthrough therapy for homozygous familial hypercholesterolaemia (HoFH) by the FDA, which is due to deliver a decision on the marketing ...

While one-third of the nearly 10,000 participants were taking cholesterol-lowering medication (or a statin), none started, stopped, or changed the type of drug during the follow-up period.

However, having too much of it can lead to severe health problems. High cholesterol, particularly low-density lipoprotein (LDL), often referred to as "bad cholesterol," is a significant risk ...

Novartis has a long way to go to make its twice-yearly cholesterol-lowering drug Leqvio the multi-billion-dollar blockbuster it is predicting – but took another step along that road today.